|
|
Iron | |
|
High-potassium foods* Potassium supplements* Salt substitutes* | |
|
Sodium | |
| Depletion or interference |
None known |
| Supportive interaction |
None known |
| Reduced drug absorption/bioavailability |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Potassium
An uncommon yet potentially serious side effect of taking ACE inhibitors is increased blood
potassium levels.1 2 3 This problem is more likely to occur
in people with advanced kidney disease. Taking potassium supplements,4
potassium-containing salt substitutes (No Salt®, Morton Salt Substitute®, and
others),5 6 7 or large amounts of high-potassium foods at the
same time as ACE inhibitors could cause life-threatening problems.8 Therefore,
people should consult their healthcare practitioner before supplementing additional potassium
and should have their blood levels of potassium checked periodically while taking ACE
inhibitors.
Sodium
In a short-term study of nine overweight men, enalapril plus a low-salt diet reduced blood
pressure more than a low-salt diet alone.9
Additionally, enalapril plus a low-salt diet resulted in better
insulin response than the low-salt diet alone. The importance of this preliminary
information for overweight people with high blood pressure is unclear.
Iron
In a double-blind study of patients who had developed a cough attributed to an ACE inhibitor,
supplementation with iron (in the form of 256 mg of ferrous sulphate per day) for four weeks
reduced the severity of the cough by a statistically significant 45%, compared with a
nonsignificant 8% improvement in the placebo group.10
1. Good CB, McDermott L, McCloskey B. Diet and serum potassium in patients on ACE inhibitors. JAMA 1995;274:538.
2. Rush JE, Merrill DD. The Safety and tolerability of lisinopril in clinical trials. J Cardiovasc Pharmacol 1987;9(Suppl 3):S99–107.
3. Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 1965–8.
4. Burnakis TG, Mioduch HJ. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia. Arch Intern Med 1984;144:2371–2.
5. Burnakis TG. Captopril and increased serum potassium levels. JAMA 1984;252:1682–3 [letter].
6. Ray K, Dorman S, Watson R. Severe hyperkalemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction. J Hum Hypertens 1999;13:717–20.
7. Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 1965–8.
8. Stoltz ML. Severe hyperkalemia during very-low-calorie diets and angiotensin converting enzyme use. JAMA 1990;264:2737–8 [letter].
9. Egan BM, Stepniakowski K. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol 1993;72:53–7.
10. Lee SC, Park SW, Kim DK, et al. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension 2001;38:166–70.
11. Threlkeld DS, ed. Diuretics and Cardiovasculars, Antihypertensives, Angiotensin Converting Enzyme Inhibitors. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Apr 1998, 165o–5p.
| |||||||